To determine the clinical significance of the EEF1A2 in patients with LUAD, immunohistochemical staining was used to detect EEF1A2 in tissue microarrays (TMAs) consisting of 78 pairs of cancer samples compared with their corresponding adjacent tissues. Here, EEF1A2 is linked to cancer.